-
Birth Control Pill YAZ Is Subject Of Ongoing Safety Study Regarding Cardiovascular Side Effects
A Comparison Of This "Fourth Generation" DRSP / EE Pill To Other Established Oral Contraceptives For Incidence Of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Heart Attack (MI), And Stroke (CVA) (Posted by Tom Lamb at…
-
Beware The Potential Dangers Of Free Drug Samples
Some Ways That Free Drug Samples Can Harm Patients (Posted by Tom Lamb at DrugInjuryWatch.com) PLoS Medicine— which is a peer-reviewed open-access journal published by the Public Library of Science — published an essay…
-
May 2009 Digoxin Recall By AS Medication Solutions Seems To Be About Six-Weeks Late
This Company Repackaged Caraco Digoxin Tablets That Were Recalled March 31, 2009; Why Did They Delay Their Recall Notice? (Posted by Tom Lamb at DrugInjuryWatch.com) On May 11, 2009 AS Medication Solutions, LLC —…
-
Possible Heparin-Related Deaths In Delaware Are Different Than Last Year’s Illness Outbreak
These New Cases Involve Premixed IV Bags of Heparin And Initial Tests Did Not Detect Oversulfated Chondroitin Sulfate Contamination (Posted by Tom Lamb at DrugInjuryWatch.com) The headline used by the Wall Street Journal (WSJ),…
-
Some Reasons To Support The Medical Device Safety Act Of 2009, And A Dissent
May 12 Hearing In Washington Begins The Debate About Whether The Medical Device Industry Should Have Total Immunity From Legal Liability (Posted by Tom Lamb at DrugInjuryWatch.com) On May 12, 2009 the Health Subcommittee…
-
Hydroxycut Weight-Loss Products Are Recalled Due To Cases Of Serious Liver Injury
Reports Made To The FDA Have Involved Hepatitis, Liver Failure, Liver Transplant, And Death (Posted by Tom Lamb at DrugInjuryWatch.com) On May 1, 2009 the FDA warned people to stop using Hydroxycut products – made…
